CASI Pharmaceuticals, Inc. (CASIF): SCHEDULE 13D/A filed Jan 20, 2026

Form type

SCHEDULE 13D/A

Filing date

Jan 20, 2026

Accession number

0000929638-26-000185

Filer

CASI Pharmaceuticals, Inc. (CIK 1962738)